Cargando…

Improving VTE risk assessment and prophylaxis prescribing rate in medical patients: integrating risk assessment tool into the workflow

Medical inpatients often have important risk factors for venous thromboembolism (VTE). In our institution, VTE prophylaxis in this group was underused. The main barriers identified were inattention to VTE prophylaxis, competing priorities and lack of confidence in the decision-making. We aimed to im...

Descripción completa

Detalles Bibliográficos
Autores principales: Preston, Hannah, Swan, Iain, Davies, Lauren, Dummer, Simon, Veiraiah, Aravindan, Beh, Yuan Ye, Lockman, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295437/
https://www.ncbi.nlm.nih.gov/pubmed/32540948
http://dx.doi.org/10.1136/bmjoq-2019-000903
_version_ 1783546645191852032
author Preston, Hannah
Swan, Iain
Davies, Lauren
Dummer, Simon
Veiraiah, Aravindan
Beh, Yuan Ye
Lockman, Ann
author_facet Preston, Hannah
Swan, Iain
Davies, Lauren
Dummer, Simon
Veiraiah, Aravindan
Beh, Yuan Ye
Lockman, Ann
author_sort Preston, Hannah
collection PubMed
description Medical inpatients often have important risk factors for venous thromboembolism (VTE). In our institution, VTE prophylaxis in this group was underused. The main barriers identified were inattention to VTE prophylaxis, competing priorities and lack of confidence in the decision-making. We aimed to improve the rate of VTE prophylaxis use by introducing a paper-based risk assessment tool, with actionable management recommendations within the prescription chart. The rationale was that an assessment tool at the point of prescribing can reduce steps between decision-making and prescribing process, thus promoting confidence and acting as a reminder. A total of 552 prescription charts completed over a period of 29 weeks were examined during the baseline period. In the postintervention period, 871 charts completed over 40 weeks period were examined. The risk assessment tool was completed in 51% of the cases examined in the postintervention period. The introduction of the risk assessment tool was associated with a significant change in the pattern of VTE pharmacological prophylaxis use. The change occurred when the form was made highly visible and enclosed in the prescription chart. The pharmacological prophylaxis use was higher with a completed assessment form than without (mean (SD) 97.5% (7.6%) vs 70.1% (19.4%); p<0.0001). The rate of appropriate prophylaxis decision was 98.2% (SD 5.2%) with a completed assessment form, and 80.7% (SD 17.9%) when it was not used. The qualitative interviews revealed positive themes; many users found it useful, easy and convenient to use. Our data have shown that a paper-based VTE risk assessment tool placed within the prescription chart could substantially improve the rate of appropriate assessment and VTE prophylaxis implementation. This suggests that tool clearly needs to be a seamless integration into the workflow to capture users’ attention and mitigate the influence of time perception.
format Online
Article
Text
id pubmed-7295437
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-72954372020-06-19 Improving VTE risk assessment and prophylaxis prescribing rate in medical patients: integrating risk assessment tool into the workflow Preston, Hannah Swan, Iain Davies, Lauren Dummer, Simon Veiraiah, Aravindan Beh, Yuan Ye Lockman, Ann BMJ Open Qual Quality Improvement Report Medical inpatients often have important risk factors for venous thromboembolism (VTE). In our institution, VTE prophylaxis in this group was underused. The main barriers identified were inattention to VTE prophylaxis, competing priorities and lack of confidence in the decision-making. We aimed to improve the rate of VTE prophylaxis use by introducing a paper-based risk assessment tool, with actionable management recommendations within the prescription chart. The rationale was that an assessment tool at the point of prescribing can reduce steps between decision-making and prescribing process, thus promoting confidence and acting as a reminder. A total of 552 prescription charts completed over a period of 29 weeks were examined during the baseline period. In the postintervention period, 871 charts completed over 40 weeks period were examined. The risk assessment tool was completed in 51% of the cases examined in the postintervention period. The introduction of the risk assessment tool was associated with a significant change in the pattern of VTE pharmacological prophylaxis use. The change occurred when the form was made highly visible and enclosed in the prescription chart. The pharmacological prophylaxis use was higher with a completed assessment form than without (mean (SD) 97.5% (7.6%) vs 70.1% (19.4%); p<0.0001). The rate of appropriate prophylaxis decision was 98.2% (SD 5.2%) with a completed assessment form, and 80.7% (SD 17.9%) when it was not used. The qualitative interviews revealed positive themes; many users found it useful, easy and convenient to use. Our data have shown that a paper-based VTE risk assessment tool placed within the prescription chart could substantially improve the rate of appropriate assessment and VTE prophylaxis implementation. This suggests that tool clearly needs to be a seamless integration into the workflow to capture users’ attention and mitigate the influence of time perception. BMJ Publishing Group 2020-06-14 /pmc/articles/PMC7295437/ /pubmed/32540948 http://dx.doi.org/10.1136/bmjoq-2019-000903 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Quality Improvement Report
Preston, Hannah
Swan, Iain
Davies, Lauren
Dummer, Simon
Veiraiah, Aravindan
Beh, Yuan Ye
Lockman, Ann
Improving VTE risk assessment and prophylaxis prescribing rate in medical patients: integrating risk assessment tool into the workflow
title Improving VTE risk assessment and prophylaxis prescribing rate in medical patients: integrating risk assessment tool into the workflow
title_full Improving VTE risk assessment and prophylaxis prescribing rate in medical patients: integrating risk assessment tool into the workflow
title_fullStr Improving VTE risk assessment and prophylaxis prescribing rate in medical patients: integrating risk assessment tool into the workflow
title_full_unstemmed Improving VTE risk assessment and prophylaxis prescribing rate in medical patients: integrating risk assessment tool into the workflow
title_short Improving VTE risk assessment and prophylaxis prescribing rate in medical patients: integrating risk assessment tool into the workflow
title_sort improving vte risk assessment and prophylaxis prescribing rate in medical patients: integrating risk assessment tool into the workflow
topic Quality Improvement Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295437/
https://www.ncbi.nlm.nih.gov/pubmed/32540948
http://dx.doi.org/10.1136/bmjoq-2019-000903
work_keys_str_mv AT prestonhannah improvingvteriskassessmentandprophylaxisprescribingrateinmedicalpatientsintegratingriskassessmenttoolintotheworkflow
AT swaniain improvingvteriskassessmentandprophylaxisprescribingrateinmedicalpatientsintegratingriskassessmenttoolintotheworkflow
AT davieslauren improvingvteriskassessmentandprophylaxisprescribingrateinmedicalpatientsintegratingriskassessmenttoolintotheworkflow
AT dummersimon improvingvteriskassessmentandprophylaxisprescribingrateinmedicalpatientsintegratingriskassessmenttoolintotheworkflow
AT veiraiaharavindan improvingvteriskassessmentandprophylaxisprescribingrateinmedicalpatientsintegratingriskassessmenttoolintotheworkflow
AT behyuanye improvingvteriskassessmentandprophylaxisprescribingrateinmedicalpatientsintegratingriskassessmenttoolintotheworkflow
AT lockmanann improvingvteriskassessmentandprophylaxisprescribingrateinmedicalpatientsintegratingriskassessmenttoolintotheworkflow